简介内容：KPH2f, a dual URAT1/GLUT9 inhibitor, demonstrates safety, oral activity, and efficacy, with inhibitory concentrations (IC50s) of μM for URAT1 and μM for GLUT9. It exhibits minimal effects on OAT1 and ABCG2, with IC50 values of μM and μM, respectively [1].
Customer Service
